By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
| Currency | US Dollars |
| Share Price | $ 121.26 |
| Change Today | $ -2.81 |
| % Change | -2.26 % |
| 52 Week High | $128.07 |
| 52 Week Low | $91.65 |
| Volume | 6,659,785 |
| Shares Issued | 1,246.00m |
| Market Cap | $151,090m |
| RiskGrade | 120 |
| Time | Volume / Share Price |
| 16:00 | 400 @ $121.35 |
| 16:00 | 900 @ $121.33 |
| 15:59 | 100 @ $121.27 |
| 15:59 | 200 @ $121.24 |
| 15:59 | 100 @ $121.24 |
You are here: research